Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
3
×
life sciences
3
×
national blog main
boston blog main
boston top stories
indiana blog main
indiana top stories
480 biomedical
aimmune therapeutics
allergy
amgen
anaphylaxis
andrew oxtoby
arsenal medical
bob langer
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
chronic rhinosinusitis
covid-19
daniel edelman
deals
detroit blog main
detroit top stories
drug delivery
drugs
eli lilly
eosinophilic esophagitis
episodic migraine
food allergy
genzyme
george whitesides
immunotherapy
indiana
inflammation
investing
What
late
3
×
approval
approved
developed
drug
fda
new
therapeutics
treat
won
agency
aimmune
allergy
announced
awarded
biotech
class
company
debut
decision
developing
eli
friday
headache
immunotherapy
ipo
lilly
lyra
markets
marks
medicines
migraine
million
nose
noses
oral
pain
peanut
persistently
prevent
Language
unset
Current search:
late
×
fda
×
" life sciences "
×
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines